
PureTech Health plc — Investor Relations & Filings
PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Holding(s) in Company | 2026-05-29 | English | |
| Holding(s) in Company | 2026-05-27 | English | |
| Holding(s) in Company | 2026-05-22 | English | |
| Correction - Holding(s) in Company | 2026-05-15 | English | |
| PRTC To Showcase Deupirfenidone at ATS Conference | 2026-05-13 | English | |
| Holding(s) in Company | 2026-05-08 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47891182 | Holding(s) in Company | 2026-05-29 | English | ||
| 47777829 | Holding(s) in Company | 2026-05-27 | English | ||
| 46846084 | Holding(s) in Company | 2026-05-22 | English | ||
| 46349644 | Correction - Holding(s) in Company | 2026-05-15 | English | ||
| 45566389 | PRTC To Showcase Deupirfenidone at ATS Conference | 2026-05-13 | English | ||
| 44107110 | Holding(s) in Company | 2026-05-08 | English | ||
| 43307615 | Holding(s) in Company | 2026-05-07 | English | ||
| 39399460 | PureTech's Seaport Prices Upsized IPO Nasdaq: SPTX | 2026-05-01 | English | ||
| 38655488 | Notice of Meeting for 2026 AGM | 2026-04-29 | English | ||
| 38642553 | Proxy Form for 2026 AGM | 2026-04-29 | English | ||
| 38637441 | 20-F - PureTech Health plc (0001782999) (Filer) | 2026-04-29 | English | ||
| 38625474 | Annual Report and Accounts 2025 | 2026-04-29 | English | ||
| 38625445 | Annual Report and Accounts 2025 | 2026-04-29 | English | ||
| 38495071 | 6-K - PureTech Health plc (0001782999) (Filer) | 2026-04-29 | English | ||
| 38494876 | 6-K - PureTech Health plc (0001782999) (Filer) | 2026-04-29 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for PureTech Health plc, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aquestive Therapeutics, Inc.
Pharmaceutical company developing oral film medicines for C…
|
AQST | US | Manufacturing |
|
Arbutus Biopharma Corp
Clinical-stage biopharma company developing a functional cu…
|
ABUS | US | Manufacturing |
|
Arcellx, Inc.
A clinical-stage biotech company developing immunotherapies…
|
ACLX | US | Manufacturing |
|
Arctic Bioscience
Develops pharmaceutical and nutraceutical products from mar…
|
ABS | NO | Manufacturing |
|
ArcticZymes Technologies
Develops and manufactures novel recombinant enzymes from Ar…
|
AZT | NO | Manufacturing |
|
Arcturus Therapeutics Holdings Inc.
A commercial-stage mRNA medicines company focused on rare a…
|
ARCT | US | Manufacturing |
|
Arcus Biosciences, Inc.
A clinical-stage biopharmaceutical company developing combi…
|
RCUS | US | Manufacturing |
|
Arcutis Biotherapeutics, Inc.
Develops and commercializes treatments for immune-mediated …
|
ARQT | US | Manufacturing |
|
ARDELYX, INC.
Biopharmaceutical company developing medicines for cardiore…
|
ARDX | US | Manufacturing |
|
ARECOR THERAPEUTICS PLC
Biopharmaceutical company enhancing medicines with its prop…
|
AREC | GB | Manufacturing |
PureTech Health plc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/4932/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=4932 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=4932 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=4932 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 4932}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PureTech Health plc (id: 4932)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.